Abingdon Health Plc (ABDX.L)
GBp 6.0
(0.0%)
GBp 6.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.65 Million | 1 Million | -7.73 Million | -12.87 Million | 2.09 Million | -908.25 Thousand |
| Net Income | -1.27 Million | -3.45 Million | -21.26 Million | -6.97 Million | -3.37 Million | -1.26 Million |
| Depreciation & Amortization | 426 Thousand | 673 Thousand | 1.63 Million | 749 Thousand | 225 Thousand | 289.14 Thousand |
| Deferred income taxes | - | 2.29 Million | -8.86 Million | -11.04 Million | 14.94 Thousand | 344.54 Thousand |
| Stock-based compensation | 48 Thousand | 28 Thousand | 231 Thousand | 1.36 Million | 36 Thousand | 33.67 Thousand |
| Change in working capital | -744 Thousand | 3.67 Million | -5.35 Million | -8.17 Million | 1.2 Million | -279.14 Thousand |
| Other non-cash items | -118 Thousand | -2.21 Million | 25.88 Million | 11.2 Million | 3.99 Million | -36.39 Thousand |
| Investing Cash Flow | -23 Thousand | -156 Thousand | -760 Thousand | -7.27 Million | -1.93 Million | -79.24 Thousand |
| Investments in PPE | -41 Thousand | -157 Thousand | -760 Thousand | -7.25 Million | -1.65 Million | -96.21 Thousand |
| Acquisitions | - | 1000.00 | -32 Thousand | -24 Thousand | -280 Thousand | -175 Thousand |
| Investment purchases | -13 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 25 Thousand | -1000.00 | 32 Thousand | -105 Thousand | -8000.00 | 191.97 Thousand |
| Financing Cash Flow | -114 Thousand | -7000.00 | 5.91 Million | 20.74 Million | 3.36 Million | 1.37 Million |
| Debt repayment | -114 Thousand | -135 Thousand | -42 Thousand | -251 Thousand | -137 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 6.13 Million | 20.7 Million | - | 1.5 Million |
| Other Financing Activities | -114 Thousand | 128 Thousand | -179 Thousand | 289 Thousand | 3.5 Million | -123.26 Thousand |
| Accounts receivables | -297 Thousand | 6.64 Million | 2.13 Million | -8.1 Million | 1.57 Million | -460.29 Thousand |
| Accounts payables | -335 Thousand | -3.18 Million | -5.17 Million | 7.03 Million | 2.68 Million | 198.39 Thousand |
| Inventory | -112 Thousand | 205 Thousand | -2.32 Million | -7.1 Million | -373 Thousand | -17.24 Thousand |
| Other working capital | -335 Thousand | -3.18 Million | - | - | -2.68 Million | - |
| Cash at beginning of period | 3.23 Million | 2.39 Million | 4.97 Million | 4.38 Million | 866.15 Thousand | 476.9 Thousand |
| Cash at end of period | 1.44 Million | 3.23 Million | 2.39 Million | 4.97 Million | 4.38 Million | 866.15 Thousand |
| Capital Expenditure | -41 Thousand | -157 Thousand | -760 Thousand | -7.25 Million | -1.65 Million | -96.21 Thousand |
| Effect of forex changes on cash | - | - | - | -241.00 | 866 Thousand | - |
| Net cash flow / Change in cash | -1.79 Million | 839 Thousand | -2.58 Million | 588.75 Thousand | 3.52 Million | 389.24 Thousand |
| Free Cash Flow | -1.7 Million | 845 Thousand | -8.49 Million | -20.12 Million | 445 Thousand | -1 Million |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -66 Thousand | -1.2 Million | -1.03 Million | -3.45 Million | -2.42 Million | -21.26 Million |
| Depreciation & Amortization | 141 Thousand | 285 Thousand | 343 Thousand | 673 Thousand | 330 Thousand | 1.63 Million |
| Deferred income taxes | - | -187 Thousand | -1.33 Million | 2.29 Million | 3.63 Million | -8.86 Million |
| Stock-based compensation | 38 Thousand | 10 Thousand | 21 Thousand | 28 Thousand | 7000.00 | 231 Thousand |
| Change in working capital | -475 Thousand | 66 Thousand | -631 Thousand | 3.67 Million | 4.3 Million | -5.35 Million |
| Other non-cash items | -98 Thousand | -355 Thousand | 1.64 Million | -2.21 Million | -3.85 Million | 25.88 Million |
| Investing Cash Flow | -27 Thousand | 4000.00 | -98 Thousand | -156 Thousand | -58 Thousand | -760 Thousand |
| Investments in PPE | -17 Thousand | -18 Thousand | -99 Thousand | -157 Thousand | -58 Thousand | -760 Thousand |
| Acquisitions | - | - | 1000.00 | 1000.00 | - | -32 Thousand |
| Investment purchases | -13 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10 Thousand | 22 Thousand | -7000.00 | -1000.00 | 14 Thousand | 32 Thousand |
| Financing Cash Flow | -71 Thousand | -43 Thousand | -121 Thousand | -7000.00 | 114 Thousand | 5.91 Million |
| Debt repayment | - | -43 Thousand | -135 Thousand | -135 Thousand | -187 Thousand | -42 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 6.13 Million |
| Other Financing Activities | -71 Thousand | -43 Thousand | -1000.00 | 128 Thousand | 114 Thousand | -179 Thousand |
| Accounts receivables | -446 Thousand | 149 Thousand | -373 Thousand | 6.64 Million | 7.02 Million | 2.13 Million |
| Accounts payables | -662 Thousand | 327 Thousand | -112 Thousand | -3.18 Million | -3.06 Million | -5.17 Million |
| Inventory | -29 Thousand | -83 Thousand | -146 Thousand | 205 Thousand | 351 Thousand | -2.32 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.99 Million | 3.23 Million | 4.45 Million | 2.39 Million | 2.39 Million | 4.97 Million |
| Cash at end of period | 1.44 Million | 1.99 Million | 3.23 Million | 3.23 Million | 4.45 Million | 2.39 Million |
| Capital Expenditure | -17 Thousand | -18 Thousand | -99 Thousand | -157 Thousand | -58 Thousand | -760 Thousand |
| Effect of forex changes on cash | - | 3.23 Million | -3.23 Million | - | 2.39 Million | - |
| Net cash flow / Change in cash | -558 Thousand | -1.23 Million | -1.21 Million | 839 Thousand | 2.05 Million | -2.58 Million |
| Free Cash Flow | -477 Thousand | -1.21 Million | -1.09 Million | 845 Thousand | 1.93 Million | -8.49 Million |
NATPLAS
ALPSINDUS
TOYOF
BCHEY
CEG
AJLGF